08:00 , Dec 6, 2010 |  BC Week In Review  |  Company News

Biosystems International, Pharnext, Bordeaux Hospital, INSERM, OSEO, University Bordeaux Segalen neurology news

OSEO is eligible for royalties during the first three years of the deal if net sales are higher than a pre-defined, undisclosed figure. Biosystems International S.A.S. , Evry, France   Pharnext S.A.S. , Paris, France...
07:00 , Jul 26, 2010 |  BC Week In Review  |  Financial News

Biosystems International completes venture financing

Biosystems International S.A.S. , Evry, France   Business: Diagnostic, Cancer, Metabolic   Date completed: 7/19/10   Type: Venture financing   Raised: €2.1 million ($2.7 million)   Investors: Amundi Asset Management; private investors  ...
07:00 , Jun 15, 2009 |  BC Week In Review  |  Company News

Biosystems International, Lohocla Research Corp. deal

Lohocla received a license to use Biosystems International's mAb proteomics technology to discover blood-based biomarkers of alcohol-induced liver disease. Further terms were not disclosed. Lohocla discovers and develops biomarkers for neurologic conditions, including depression. Biosystems...
07:00 , Jun 8, 2009 |  BC Week In Review  |  Clinical News

in vitro diagnostic blood test: Pilot trial start

Data from discovery and validation trials of blood samples from 367 lung cancer patients and 304 healthy controls showed that Biosystems' in vitro diagnostic blood test for lung cancer had >80% sensitivity and specificity. The...
07:00 , Oct 13, 2008 |  BC Week In Review  |  Company News

Biosystems International, Integrated Media Holdings Inc. deal

Integrated Media's Arrayit Co. business received an exclusive, worldwide license to use BioSystems' Plasma Scan antibody library to develop microarrays to identify proteins expressed in human plasma. The microarrays will be developed as diagnostics. The...
07:00 , May 28, 2007 |  BC Week In Review  |  Company News

Biocrates Life Sciences GmbH, BioSystems International, Ipsogen SAS, Institut Curie, Institut Gustave Roussy, University of Debrecen, University of Innsbruck, U

The parties received a E2.9 million ($3.9 million) grant from the EU's Sixth Framework Program as part of the COBRED project. The project's goal is to discover and develop breast and colon cancer biomarkers by...
07:00 , Mar 19, 2007 |  BC Week In Review  |  Company News

BioSystems International management update

BioSystems International , Evry, France   Business: Diagnostic   Hired: Jean Pierre Tirouflet as CEO, formerly chairman and CEO of Rhodia  ...
23:56 , Mar 12, 2007 |  BC Extra  |  Company News

BioSystems names Tirouflet CEO

Diagnostic company BioSystems International (Evry, France) hired Jean Pierre Tirouflet as CEO. He was most recently chairman and CEO of French specialty chemicals company Rhodia ....
08:00 , Mar 20, 2006 |  BC Week In Review  |  Company News

BioSystems International, Northeastern University deal

The university granted BioSystems an exclusive worldwide license to a monoclonal antibody-based technology for biomarker discovery. BioSystems plans to use the technology to discover targets and for veterinary, agricultural, food and biohazard applications. Further terms...
08:00 , Feb 27, 2006 |  BC Week In Review  |  Company News

BioSystems International, AstraZeneca deal

The companies partnered to identify biomarkers for osteoporosis. The deal combines BioSystems' biomarker validation technologies with clinical samples from AZN. The pharma company will provide funding and will have exclusive rights to any new targets...